SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ:AFFX) today announced that the U.S. Food and Drug Administration has cleared the addition of new gene expression reagents as accessories ...

At first glance, the luminous image rolling across a conference room wall at Affymetrix Inc. looks like mysterious transmissions from an alien race using an intricate language we don't understand. But ...

Affymetrix, Inc. (NASDAQ:AFFX) today announced that it has signed a distribution agreement with Fisher Scientific, Inc., part of Thermo Fisher Scientific, to distribute the GeneAtlas™ System and its ...

Kits will be configured for use with the GeneChip System 3000Dx v.2. Asuragen is to develop and manufacture RNA Control Kits for Affymetrix for use with its in vitro transcription reagent kits for ...

We’ll also continue to sell the GeneChip system on the diagnostic side to many customers as well, so that product will continue to go forward. Doug Schenkel - Cowen and Company Panomics is an RNA ...

Affymetrix, the Santa Clara maker of tools used to study DNA and diagnose diseases, was sued for patent infringement by the Massachusetts Institute of Technology over the company’s GeneChip system ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix Inc. (Nasdaq:AFFX) announced today that it has entered into a definitive agreement to acquire Panomics Inc., a privately held Fremont, Calif.-based ...

NEW YORK (CBS.MW) -- Affymetrix Inc. said Monday the U.S. Food and Drug Administration has approved its GeneChip system 3000Dx, an instrumentation system to analyze in vitro diagnostic microarrays.

SAN DIEGO & SANTA CLARA, Calif., Jan 10, 2008 - Affymetrix and Illumina, Inc. (NASDAQ:ILMN) announced today that they have entered into a settlement agreement to resolve their patent litigation. Under ...

Unique and optimized solution provides highly sensitive and reproducible RNA amplification and labeling from archived FFPE samples for biomarker discovery and validation on industry-leading ...

Affymetrix, Inc. and DNA Link, Inc., a Korean genomics-based biotechnology company, have signed a Powered by Affymetrix (PbA) Programme agreement in which DNA Link, Inc. obtains a worldwide license to ...

Microarrays have been widely used for the analysis of gene expression, but the issue of reproducibility across platforms has yet to be fully resolved. To address this apparent problem, we compared ...